148 related articles for article (PubMed ID: 34425868)
1. Comprehensive analysis of metabolism-related lncRNAs related to the progression and prognosis in osteosarcoma from TCGA.
Chen X; Ye Z; Lou P; Liu W; Liu Y
J Orthop Surg Res; 2021 Aug; 16(1):523. PubMed ID: 34425868
[TBL] [Abstract][Full Text] [Related]
2. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
3. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of a ceRNA Network Identifies lncR-C3orf35 Associated with Poor Prognosis in Osteosarcoma.
Shi Y; Ren J; Zhuang Z; Zhang W; Wang Z; Liu Y; Li J; Liang T; He R; Wang K
Biomed Res Int; 2020; 2020():3178037. PubMed ID: 33015161
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
6. A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma.
Zheng Y; Xu J; Lin J; Lin Y
Comput Math Methods Med; 2022; 2022():8003525. PubMed ID: 35844445
[TBL] [Abstract][Full Text] [Related]
7. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
8. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
9. The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma.
Jiang J; Chu D; Lai X; Liu L; Tao J
Comput Math Methods Med; 2022; 2022():6314182. PubMed ID: 36388161
[TBL] [Abstract][Full Text] [Related]
10. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
11. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
12. A novel autophagy-related lncRNA survival model for lung adenocarcinoma.
Wu L; Wen Z; Song Y; Wang L
J Cell Mol Med; 2021 Jun; 25(12):5681-5690. PubMed ID: 33987935
[TBL] [Abstract][Full Text] [Related]
13. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
Ying T; Dong JL; Yuan C; Li P; Guo Q
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
[TBL] [Abstract][Full Text] [Related]
14. Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Zhang G; Fan E; Zhong Q; Feng G; Shuai Y; Wu M; Chen Q; Gou X
Hum Genomics; 2019 Aug; 13(1):36. PubMed ID: 31416476
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
16. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
20. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]